Arrowhead Pharmaceuticals, Inc. (ARWR)
63.44
-1.12
(-1.73%)
USD |
NASDAQ |
Jan 12, 11:44
Arrowhead Pharmaceuticals Research and Development Expense (Quarterly): 168.80M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 218.89M |
| Eli Lilly & Co. | 3.466B |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| Cidara Therapeutics, Inc. | 35.53M |
| Celcuity, Inc. | 34.92M |